A. Epstein

B. Diamond, M. Rosenblum, J. Dutcher, 1995, Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy.

Immunologic and biochemical analysis of TNT-1 and TNT-2 monoclonal antibody binding to histones.

S. Gaffar, A. Epstein, G. S. Naeve, 1993, Hybridoma.

The evaluation of 186Re-labeled antibodies using N2S4 chelate in vitro and in vivo using tumor-bearing nude mice.

A. Epstein, M. Alauddin, M. Siegel, 1992, International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology.

Nuclear Localization of PTTG1 Promotes Migration and Invasion of Seminoma Tumor through Activation of MMP-2

F. Mancini, G. Maulucci, F. Di Nicuolo, 2020, Cancers.

An improved method of direct labeling monoclonal antibodies with 99mTc.

L. Khawli, A. Epstein, M. Alauddin, 1992, International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology.

Combined immune checkpoint blockade increases CD8+CD28+PD-1+ effector T cells and provides a therapeutic strategy for patients with neuroblastoma

M. Fabbri, G. E. Fernandez, H. Shimada, 2021, Oncoimmunology.

Technetium-99m-labeled proteins for imaging inflammatory foci.

M. Thakur, A. Epstein, J. McAfee, 1991, International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology.

Antitumor effects of nonconjugated murine Lym-2 and human-mouse chimeric CLL-1 monoclonal antibodies against various human lymphoma cell lines in vitro and in vivo.

D. Longo, L. Khawli, M. Beckwith, 1997, Blood.

Modulation of Treg cells/T effector function by GITR signaling is context–dependent

D. Glass, E. Shevach, A. Epstein, 2013, European journal of immunology.

Antibodies to Brewer's Yeast in Rheumatoid Arthritis

A. Epstein, J. Lichtenstein, 2019, Cureus.

Construction and Preclinical Characterization of Fc-mGITRL for the Immunotherapy of Cancer

L. Khawli, H. Sabzevari, A. Epstein, 2008, Clinical Cancer Research.

OX40L-JAG1–Induced Expansion of Lineage-Stable Regulatory T Cells Involves Noncanonical NF-κB Signaling

B. Prabhakar, A. Epstein, S. Chiba, 2019, The Journal of Immunology.

PKC-ѳ is dispensable for OX40L-induced TCR-independent Treg proliferation but contributes by enabling IL-2 production from effector T-cells

Osama M. El-Sayed, B. Prabhakar, A. Maker, 2017, Scientific Reports.

Establishment and characterization of a new human extragonadal germ cell line, SEM-1, and its comparison with TCam-2 and JKT-1.

L. Looijenga, C. French, A. Epstein, 2013, Urology.

Quantitative analysis of a nuclear antigen in interphase and mitotic cells.

K. Bauer, A. Epstein, C. Clevenger, 1987, Cytometry.

Assessment of cell cycle-associated antigen expression using multiparameter flow cytometry and antibody-acridine orange sequential staining.

K. Bauer, A. Epstein, T. Williams, 1986, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

Effect of seven new vasoactive immunoconjugates on the enhancement of monoclonal antibody uptake in tumors

L. Khawli, A. Epstein, G. K. Miller, 1994, Cancer.

Radioimmunodetection of human B-cell lymphomas with a radiolabeled tumor-specific monoclonal antibody (Lym-1)

A. M. Zimmer, G. Denardo, S. Denardo, 1985 .

Critical role of OX40 signaling in the TCR-independent phase of human and murine thymic Treg generation

B. Prabhakar, A. Maker, A. Epstein, 2018, Cellular & Molecular Immunology.

123I radiolabeling of monoclonal antibodies for in vivo procedures.

G. Denardo, S. Denardo, A. Epstein, 1986, Hybridoma.

Effect of mass of 111In-benzyl-EDTA monoclonal antibody on hepatic uptake and processing in mice.

G. Denardo, S. Denardo, G. Adams, 1989, Cancer research.

The Design of a Radiolabeled Monoclonal Antibody for Radioimmunodiagnosis and Radioimmunotherapy

G. Denardo, S. Denardo, G. Adams, 1988 .

Identification of a protein fragment of interleukin 2 responsible for vasopermeability.

L. Khawli, A. Epstein, Jiali Li, 2003, Journal of the National Cancer Institute.

Enhanced tumor uptake of macromolecules induced by a novel vasoactive interleukin 2 immunoconjugate.

L. Khawli, A. Epstein, M. Alauddin, 1991, Cancer research.

Improving monoclonal antibody pharmacokinetics via chemical modification.

L. Khawli, J. Hornick, A. Epstein, 1998, The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology.

Comparative serum stability of radiochelates for antibody radiopharmaceuticals.

G. Denardo, S. Denardo, A. Epstein, 1987, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Molecular profiling reveals a hypoxia signature in breast implant-associated anaplastic large cell lymphoma

A. Feldman, L. Medeiros, Y. Salama, 2020, Haematologica.

Phenotypic analysis of established diffuse histiocytic lymphoma cell lines utilizing monoclonal antibodies and cytochemical techniques

J. Winter, A. Epstein, D. Variakojis, 1984 .

Phenotypic analysis of established diffuse histiocytic lymphoma cell lines utilizing monoclonal antibodies and cytochemical techniques.

J. Winter, A. Epstein, D. Variakojis, 1984, Blood.

Therapeutic Vaccination in a Mouse Model of Regression Induced by Fc-OX40L and Independent Tumor - T Cell + CD8

A. Epstein, K. Murphy, J. Erickson, 2017 .

Comparison of three different targeted tissue factor fusion proteins for inducing tumor vessel thrombosis.

L. Khawli, Jianghua Yan, A. Epstein, 2003, Cancer research.

Comparison of Three Different Targeted Tissue Factor Fusion Proteins for Inducing Tumor Vessel Thrombosis 1

L. Khawli, Jianghua Yan, A. Epstein, 2003 .

Monoclonal LYM‐1 antibody‐dependent cytolysis by human neutrophils exposed to GM‐CSF: auto‐regulation of target cell attack by cathepsin G

A. Epstein, F. Dallegri, L. Ottonello, 2004, Journal of leukocyte biology.

Monoclonal Lym‐1 antibody‐targeted lysis of B lymphoma cells by neutrophils. Evidence for two mechanisms of FcγRII‐dependent cytolysis

A. Epstein, F. Dallegri, L. Ottonello, 2000, Journal of leukocyte biology.

Restoration of Follicular T Regulatory/Helper Cell Balance by OX40L–JAG1 Cotreatment Suppresses Lupus Nephritis in NZBWF1/j Mice

B. Prabhakar, S. Setty, A. Epstein, 2022, The Journal of Immunology.

Two new monoclonal antibodies, Lym-1 and Lym-2, reactive with human B-lymphocytes and derived tumors, with immunodiagnostic and immunotherapeutic potential.

J. Winter, A. Epstein, E. Stathopoulos, 1987, Cancer research.

Generation of low-toxicity interleukin-2 fusion proteins devoid of vasopermeability activity.

L. Khawli, A. Epstein, P. Hu, 2003, Blood.

Combination immunotherapy with anti-CD20 and anti-HLA-DR monoclonal antibodies induces synergistic anti-lymphoma effects in human lymphoma cell lines

G. Denardo, S. Denardo, C. Liu, 2007, Leukemia & lymphoma.

Biology of the human malignant lymphomas I. Establishment in continuous cell culture and heterotransplantation of diffuse histiocytic lymphomas

A. Epstein, H. Kaplan, 1974, Cancer.

Adaptable antibody Nanoworms designed for non-Hodgkin lymphoma.

Caleb F. Anderson, H. Cui, Hao Su, 2020, Biomaterials.

Two new monoclonal antibodies (LN-1, LN-2) reactive in B5 formalin-fixed, paraffin-embedded tissues with follicular center and mantle zone human B lymphocytes and derived tumors.

J. Winter, A. Epstein, R. Fox, 1984, Journal of immunology.

Isolation of a type C RNA virus from an established human histiocytic lymphoma cell line.

A. Epstein, H. Kaplan, S. Gartner, 1977, Proceedings of the National Academy of Sciences of the United States of America.

Biology of the human malignant lymphomas III. Intracranial heterotransplantation in the nude, athymic mouse

M. Herman, A. Epstein, R. Dorfman, 1976, Cancer.

IL-13 is produced by tumor cells in breast implant-associated anaplastic large cell lymphoma: implications for pathogenesis.

B. Hubbard, David A. Sieber, L. Medeiros, 2018, Human pathology.

Biomarkers Provide Clues to Early Events in the Pathogenesis of Breast Implant-Associated Anaplastic Large Cell Lymphoma.

R. Macleod, W. Adams, A. Epstein, 2016, Aesthetic surgery journal.

Immunohistologic identification of phenotypic antigens associated with Hodgkin and reed‐sternberg cells. A paraffin section study

A. Sherrod, A. Epstein, R. Lukes, 1986, Cancer.

Sensitivity and specificity of immunostaining in the diagnosis of mantle zone lymphoma.

B. Nathwani, J. Said, A. Epstein, 1986, American journal of clinical pathology.

Deletion of monoamine oxidase A in a prostate cancer model enhances anti-tumor immunity through reduced immune suppression.

J. Shih, A. Epstein, Julie K. Jang, 2022, Biochemical and biophysical research communications.

Immunohistochemical analysis of human lymphomas with monoclonal antibodies to B cell and Ia antigens reactive in paraffin sections.

A. Epstein, D. Variakojis, R. Marder, 1985, Laboratory investigation; a journal of technical methods and pathology.

Monoclonal antibodies reactive with B‐lymphocytes and histiocytes in paraffin sections

A. Epstein, R. Lukes, B. Felder, 1985, Cancer.

Expression of the luteinizing hormone receptor (LHR) in ovarian cancer

J. Pinski, A. Epstein, L. Roman, 2019, BMC Cancer.

Immunohistologic Techniques: Their Impact in Tumor Diagnosis with Particular Reference to Lymphomas

A. Sherrod, A. Epstein, F. Hofman, 1985 .

Effects of131I-labeled TNT-1 radioimmunotherapy on HT-29 human colon adenocarcinoma spheroids

A. Epstein, Feng-Ming Chen, Chang-zheng Liu, 2005, Cancer Immunology, Immunotherapy.

Combination B7-Fc Fusion Protein Treatment and Treg Cell Depletion Therapy

L. Khawli, A. Epstein, P. Hu, 2005, Clinical Cancer Research.

Combination B 7-Fc Fusion ProteinTreatment and Treg Cell

L. Khawli, A. Epstein, P. Hu, 2005 .

Treatment of B cell malignancies with 131I LYM‐1 monoclonal antibodies

G. Denardo, S. Denardo, A. Epstein, 1988, International journal of cancer. Supplement = Journal international du cancer. Supplement.

Lym-1-induced apoptosis of non-Hodgkin's lymphomas produces regression of transplanted tumors.

L. Khawli, A. Epstein, N. Zhang, 2007, Cancer biotherapy & radiopharmaceuticals.

Rapidly Fatal Pulmonary Fibrosis in a Patient with Psoriatic Arthritis Treated with Adalimumab

A. Epstein, Brian C. Capell, P. Kinniry, 2011, The Journal of Rheumatology.

A chimeric Lym-1/interleukin 2 fusion protein for increasing tumor vascular permeability and enhancing antibody uptake.

P. Anderson, L. Khawli, J. Hornick, 1996, Cancer research.

CD8+ T Cell–Independent Tumor Regression Induced by Fc-OX40L and Therapeutic Vaccination in a Mouse Model of Glioma

G. Pluhar, A. Epstein, K. Murphy, 2014, The Journal of Immunology.

NEO100 enables brain delivery of blood-brain barrier-impermeable therapeutics.

Thomas C. Chen, A. Schönthal, Thomas C Chen, 2020, Neuro-oncology.

Application of monoclonal antibodies to tumor diagnosis and therapy.

J. Winter, S. Rosen, A. Epstein, 1983, Annals of clinical and laboratory science.

Improved immunotargeting of tumors with biotinylated monoclonal antibodies and radiolabeled streptavidin

L. Khawli, A. Epstein, M. Alauddin, 1993 .

Unique approach for B lymphoma therapy.

A. Epstein, 2012, Blood.

Serum stability of 67Cu chelates: comparison with 111In and 57Co.

G. Denardo, S. Denardo, A. Epstein, 1986, International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology.

Immunobiochemical characterization with monoclonal antibodies of Epstein-Barr virus-associated early antigens in chemically induced cells

A. Epstein, 1984, Journal of virology.

Simultaneous nuclear antigen and DNA content quantitation using paraffin-embedded colonic tissue and multiparameter flow cytometry.

K. Bauer, A. Epstein, C. Clevenger, 1986, Cancer research.

Characterization of a phage display-derived human monoclonal antibody (NHS76) counterpart to chimeric TNT-1 directed against necrotic regions of solid tumors.

L. Khawli, A. Epstein, P. Hu, 2001, Hybridoma and hybridomics.

Hyperuricemia and Gout in Orthopaedics.

Aaron Meller, A. Epstein, Feroz A. Osmani, 2018, JBJS Reviews.

A therapeutic OX40 agonist dynamically alters dendritic, endothelial, and T cell subsets within the established tumor microenvironment.

A. Epstein, W. Storkus, P. Hu, 2010, Cancer research.

Effect of Mass of ' "In-Benzyl-EDTA Monoclonal Antibody on Hepatic Uptake and Processing in Mice1

Shrikant, G. Denardo, S. Denardo, 2006 .

Radiopharmaceutical preparation of a monoclonal antibody, lym‐1, and its F(ab')2 fragment for imaging lymphoma with In‐111

G. Denardo, S. Denardo, A. Epstein, 1989 .

Brain Disposition of Antibody-Based Therapeutics: Dogma, Approaches and Perspectives

L. Khawli, A. Epstein, P. Hu, 2021, International journal of molecular sciences.

Chimaeric Lym-1 monoclonal antibody-mediated cytolysis by neutrophils from G-CSF-treated patients: stimulation by GM-CSF and role of Fcγ -receptors

A. Epstein, F. Dallegri, L. Ottonello, 2001, British Journal of Cancer.

Cell based radioimmunoassays to quantitate the immunoreactivity of TNT monoclonal antibodies directed against intracellular antigens.

S. Gaffar, A. Epstein, C. Liu, 1991, Journal of immunoassay.

Survival Signals and Targets for Therapy in Breast Implant–Associated ALK− Anaplastic Large Cell Lymphoma

A. Epstein, S. Russell, T. Angell, 2012, Clinical Cancer Research.

Flow cytometric measurements of proliferation-associated nuclear antigen p105 and DNA content in non-Hodgkin's lymphomas.

R. Turner, L. Layfield, P. Bishop, 1989, Archives of pathology & laboratory medicine.

Screening for anti-idiotypic monoclonal antibodies on paraformaldehyde-fixed lymphoma cells.

A. Epstein, M. Samoszuk, S. Sholly, 1987, Hybridoma.

Chromosome 14 translocation in african and north american burkitt's lymphoma

F. Hecht, A. Epstein, B. Kaiser‐Mccaw, 1977, International journal of cancer.

Breast implant‐associated, ALK‐negative, T‐cell, anaplastic, large‐cell lymphoma: Establishment and characterization of a model cell line (TLBR‐1) for this newly emerging clinical entity

S. Lade, H. Prince, A. Epstein, 2011, Cancer.

LEC/chTNT-3 Fusion Protein for the Immunotherapy of Experimental Solid Tumors

L. Khawli, A. Epstein, Jiali Li, 2003, Journal of immunotherapy.

Histiocytic lymphoma cell lines: immunologic and cytogenetic studies.

F. Hecht, B. Hecht, A. Epstein, 1985, Cancer genetics and cytogenetics.

Monoclonal antibodies. Their promise for tumor diagnosis, staging, and therapy.

S. Rosen, A. Epstein, J. Radosevich, 1985, Postgraduate medicine.

Use of novel chemical supplements in the establishment of three human malignant lymphoma cell lines (NU‐DHL‐1, NUDUL‐1, and NU‐AMB‐1) with chromosome 14 translocations

B. Hecht, A. Epstein, D. Variakojis, 1985, International journal of cancer.

Cloning the chromosomal breakpoint of t(14;18) human lymphomas: clustering around Jh on chromosome 14 and near a transcriptional unit on 18

S. Korsmeyer, O. Mcbride, J. P. Jensen, 1985, Cell.

This information is current as Mononuclear Cells Normal Human Peripheral Blood Myeloid-Derived Suppressor Cells from Characterization of Cytokine-Induced

A. Epstein, M. Lechner, D. Liebertz, 2010 .

Chimeric TNT-3 antibody/murine interferon-gamma fusion protein for the immunotherapy of solid malignancies.

L. Khawli, A. Epstein, Jiali Li, 2003, Hybridoma and hybridomics.

EWS and ATF-1 gene fusion induced by t(12;22) translocation in malignant melanoma of soft parts

G. Thomas, F. Speleman, O. Delattre, 1993, Nature Genetics.

Use of a newly established human cell line (SU-CCS-1) to demonstrate the relationship of clear cell sarcoma to malignant melanoma.

Ruth Kempson, A. Epstein, A. Martin, 1984, Cancer research.

A Hybrid Protein–Polymer Nanoworm Potentiates Apoptosis Better than a Monoclonal Antibody

P. Conti, Zibo Li, H. Cui, 2014, ACS nano.

Direct membrane fluorescence reaction of EBV‐carrying human lymphoblastoid cells: Blocking tests with xenogeneic antisera

G. Klein, A. Epstein, S. Bremberg, 1969, International journal of cancer.

Mucormycosis esophagitis in a patient with the acquired immunodeficiency syndrome.

A. Epstein, P. Margolis, 1994, The American journal of gastroenterology.

Newly established clear cell sarcoma (malignant melanoma of soft parts) cell line expressing melanoma-associated Melan-A antigen and overexpressing C-MYC oncogene.

Y. Maehara, H. Moritake, A. Epstein, 2002, Cancer genetics and cytogenetics.

Reduced gamma-cystathionase protein content in human malignant leukemia cell lines as measured by immunoassay with monoclonal antibody.

A. Epstein, C. G. Smith, L. Glodé, 1981, Cancer research.

Estrogen receptor analysis in chronic lymphocytic leukemia.

L. Gordon, J. Winter, O. Kucuk, 1983, Blood.

Establishment and Characterization of a Novel Head and Neck Squamous Cell Carcinoma Cell Line USC-HN1

R. Puri, Jing Han, U. Sinha, 2010, Head & neck oncology.

Establishment and Characterization of a Novel Head and Neck Squamous Cell Carcinoma Cell Line USC-HN 1

R. Puri, Jing Han, U. Sinha, 2010 .

An In Vivo Immunotherapy Screen of Costimulatory Molecules Identifies Fc-OX40L as a Potent Reagent for the Treatment of Established Murine Gliomas

Flavia E. Popescu, M. G. O’Sullivan, A. Epstein, 2012, Clinical Cancer Research.

Eliciting Anti-Cancer Immunity by Genetically Engineered Multifunctional Exosomes.

A. Epstein, H. Lenz, Qinqin Cheng, 2022, Molecular therapy : the journal of the American Society of Gene Therapy.

BRAF V600E in papillary thyroid carcinoma is associated with increased programmed death ligand 1 expression and suppressive immune cell infiltration.

A. Epstein, M. Lechner, Julie K. Jang, 2014, Thyroid : official journal of the American Thyroid Association.

Nuclear domain 10 (ND10) associated proteins are also present in nuclear bodies and redistribute to hundreds of nuclear sites after stress

E. Yu, A. Epstein, A. Epstein, 1995, Journal of cellular biochemistry.

Evaluating antibodies for their capacity to induce cell-mediated lysis of malignant B cells.

M. Glennie, A. Epstein, J. Kalden, 1998, Cancer research.

Feeder layer and nutritional requirements for the establishment and cloning of human malignant lymphoma cell lines.

A. Epstein, H. Kaplan, H S Kaplan, 1979, Cancer research.

Surface marker characteristics and Epstein-Barr virus studies of two established North American Burkitt's lymphoma cell lines.

W. Henle, G. Henle, A. Epstein, 1976, Proceedings of the National Academy of Sciences of the United States of America.

Targetable vulnerabilities in T- and NK-cell lymphomas identified through preclinical models

Joshua M. Dempster, Henry W. Long, B. Haas, 2018, Nature Communications.

Heterogeneity among the non‐Hodgkin's lymphomas. implications for autologous bone marrow transplantation with in vitro Purging using monoclonal antibodies

J. Winter, A. Epstein, R. Marder, 1988, Cancer.

Monoclonal antibody DLC‐48: An effective reagent for use in the depletion of malignant lymphoma from human bone marrow

J. Winter, A. Epstein, J. Radosevich, 1987, International journal of cancer.

Immunoglobulin gene rearrangements and expression in diffuse histiocytic lymphomas reveal cellular lineage, molecular defects, and sites of chromosomal translocation.

S. Korsmeyer, K. Siminovitch, A. Epstein, 1986, Blood.

LN-6: a monoclonal antibody to vimentin expressed in non-hematopoietic mesenchymal cells and derived tumors and reactive in B5-fixed, paraffin-embedded tissues.

A. Epstein, E. Stathopoulos, C. Taylor, 1989, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

The elimination of malignant B lymphocytes from human bone marrow using monoclonal antibodies DLC-48 and LN-1 and human serum: a preclinical study.

J. Winter, A. Epstein, R. Marder, 1989, Leukemia research.

Targetable vulnerabilities in T- and NK-cell lymphomas identified through preclinical models

Joshua M. Dempster, Henry W. Long, E. D. Jacobsen, 2018, Nature Communications.

Monomeric annexin A2 is an oxygen-regulated toll-like receptor 2 ligand and adjuvant

A. Epstein, B. Blazar, J. Ohlfest, 2016, Journal of Immunotherapy for Cancer.

Chemokines, costimulatory molecules and fusion proteins for the immunotherapy of solid tumors.

A. Epstein, S. Russell, M. Lechner, 2011, Immunotherapy.

Chimeric TNT-3/human beta-glucuronidase fusion proteins for antibody-directed enzyme prodrug therapy (ADEPT).

L. Khawli, A. Epstein, P. Hu, 2003, Cancer biotherapy & radiopharmaceuticals.

MHC Class I Loss Is a Frequent Mechanism of Immune Escape in Papillary Thyroid Cancer That Is Reversed by Interferon and Selumetinib Treatment In Vitro

A. Epstein, M. Lechner, Julie K. Jang, 2014, Clinical Cancer Research.

LINC00261 expression reduces mutation accumulation while conferring resistance to cisplatin and altering the tumor-immune microenvironment in lung adenocarcinoma

A. Epstein, D. Mullen, C. Marconett, 2023, bioRxiv.

Costimulation of type-2 innate lymphoid cells by GITR promotes effector function and ameliorates type 2 diabetes

F. Gilliland, A. Sharpe, H. Allayee, 2019, Nature Communications.

Cytokine receptor signaling is required for the survival of ALK− anaplastic large cell lymphoma, even in the presence of JAK1/STAT3 mutations

T. Waldmann, W. Xiao, E. Jaffe, 2017, Proceedings of the National Academy of Sciences.

The perichromatin region of the plant cell nucleus is the area with the strongest co-localisation of snRNA and SR proteins

A. Epstein, Z. Mikulski, J. Niedojadło, 2012, Planta.

Relationship between neutrophil lymphocyte ratio (NLR) and MDSC concentration in localized and metastatic castration resistant prostate cancer (mCRPC) patients.

J. Pinski, A. Epstein, A. Basu, 2018 .

The anticancer effects of Metformin in the male germ tumor SEM-1 cell line are mediated by HMGA1

A. Salatino, A. Brunetti, D. Foti, 2022, Frontiers in Endocrinology.

Labeling and Imaging Techniques for Quantification of Therapeutic Biologics

L. Khawli, A. Epstein, P. Hu, 2015 .

Generation of human interferon gamma and tumor Necrosis factor alpha chimeric TNT-3 fusion proteins.

L. Khawli, A. Epstein, P. Hu, 2002, Hybridoma and hybridomics.

Exploring the Therapeutic Efficacy of Glioma Vaccines Based on Allo- and Syngeneic Antigens and Distinct Immunological Costimulation Activators

Thomas C. Chen, Carol A. Kruse, Thomas C Chen, 2012, Journal of clinical & cellular immunology.

chTNT-3/hu IL-12 fusion protein for the immunotherapy of experimental solid tumors.

L. Khawli, A. Epstein, Jiali Li, 2004, Hybridoma and hybridomics.

Flow cytometric DNA and nuclear antigen content in astrocytic neoplasms.

M. Apuzzo, R. Turner, M. Apuzzo, 1988, American journal of clinical pathology.

Reduced y-Cystathionase Protein Content in Human Malignant Leukemia Cell Lines as Measured by Immunoassay with Monoclonal Antibody1

A. Epstein, Christopher G. Smith, L. Glodé, 2004 .

Immune Signatures of Murine and Human Cancers Reveal Unique Mechanisms of Tumor Escape and New Targets for Cancer Immunotherapy

A. Epstein, S. Sachsman, P. Hu, 2007, Clinical Cancer Research.

Complete regression of experimental solid tumors by combination LEC/chTNT-3 immunotherapy and CD25(+) T-cell depletion.

L. Khawli, A. Epstein, Jiali Li, 2003, Cancer research.

B7.1/NHS76: A New Costimulator Fusion Protein for the Immunotherapy of Solid Tumors

L. Khawli, A. Epstein, P. Hu, 2006, Journal of immunotherapy.

Immunohistochemical characterization of a 183 KD myeloid-specific-DNA-binding protein in B5 fixed, paraffin-embedded tissues, and bone marrow aspirates by monoclonal antibody BM-1.

A. Epstein, E. Stathopoulos, M. Samoszuk, 1987, Blood.

NAP1051, a Lipoxin A4 Biomimetic Analogue, Demonstrates Antitumor Activity Against the Tumor Microenvironment

M. Humayun, N. Petasis, A. Epstein, 2021, Molecular Cancer Therapeutics.

Principles of N-Linked Glycosylation Variations of IgG-Based Therapeutics: Pharmacokinetic and Functional Considerations

L. Khawli, A. Epstein, P. Hu, 2020, Antibodies.

Targeting macrophages for enhancing CD47 blockade-elicited lymphoma clearance and overcoming tumor-induced suppression.

J. Dang, C. Querfeld, S. Rosen, 2022, Blood.

A novel method for the detection of necrotic lesions in human cancers.

A. Epstein, C. Taylor, F. M. Chen, 1988, Cancer research.

Evidence That Some Breast Implant Associated Anaplastic Large Cell Lymphomas Arise in the Context of Allergic Inflammation

B. Hubbard, David A. Sieber, L. Medeiros, 2017 .

Immunochemical aspects of monoclonal antibodies important for radiopharmaceutical development.

G. Denardo, S. Denardo, A. Epstein, 1986, International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology.

Immunohistochemical characterization of two new monoclonal antibodies (LN-4, LN-5) reactive with human macrophage subsets and derived malignancies in B5-fixed, paraffin-embedded tissues

R. Turner, A. Epstein, E. Stathopoulos, 1988 .

Improved tumor localization and radioimaging with chemically modified monoclonal antibodies.

L. Khawli, A. Epstein, M. Alauddin, 1996, Cancer biotherapy & radiopharmaceuticals.

Adopting an alternative structure for clinical trials in immunotherapy

A. Epstein, E. T. Roussos Torres, E. R. Roussos Torres, 2021, Expert review of anticancer therapy.

A comparative autoradiographic study demonstrating differential intratumor localization of monoclonal antibodies to cell surface (Lym-1) and intracellular (TNT-1) antigens.

Z. Li, A. Epstein, C. Taylor, 1990, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Evaluation of BPA uptake in clear cell sarcoma (CCS) in vitro and development of an in vivo model of CCS for BNCT studies.

M. Kurosaka, H. Sonobe, T. Akisue, 2011, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.

A New Mechanism for Blocking Myeloid-Derived Suppressor Cells by CpG

A. Epstein, M. Lechner, 2011, Clinical Cancer Research.

Enhanced brain entry of checkpoint-inhibitory therapeutic antibodies facilitated by intraarterial NEO100 in mouse models of brain-localized malignancies.

A. Schönthal, Thomas C Chen, Ligang Chen, 2023, Journal of neurosurgery.

NHS76/PEP2, a Fully Human Vasopermeability-Enhancing Agent to Increase The Uptake and Efficacy of Cancer Chemotherapy

L. Khawli, A. Epstein, P. Hu, 2005, Clinical Cancer Research.

Costimulation of type-2 innate lymphoid cells by GITR promotes effector function and ameliorates type 2 diabetes

F. Gilliland, A. Sharpe, H. Allayee, 2019, Nature Communications.

Comparison of recombinant derivatives of chimeric TNT-3 antibody for the radioimaging of solid tumors.

L. Khawli, A. Epstein, P. Hu, 2003, Hybridoma and hybridomics.

Critical role of OX40 signaling in the TCR-independent phase of human and murine thymic Treg generation

B. Prabhakar, A. Maker, A. Epstein, 2019, Cellular & Molecular Immunology.

Boron neutron capture therapy as new treatment for clear cell sarcoma: trial on different animal model.

H. Sonobe, K. Ono, Minoru Suzuki, 2014, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.

Circulating Myeloid-Derived Suppressor Cells Predict Differentiated Thyroid Cancer Diagnosis and Extent.

S. Groshen, S. Martin, P. Singer, 2016, Thyroid : official journal of the American Thyroid Association.

131I-chTNT radioimmunotherapy of 43 patients with advanced lung cancer.

L. Khawli, Changying Jiang, A. Epstein, 2006, Cancer biotherapy & radiopharmaceuticals.

A Rare Case of Noninsulinoma Pancreatogenous Hypoglycemia Syndrome

A. Epstein, J. Nadelson, 2012, Case reports in gastrointestinal medicine.

Eosinophil peroxidase is detectable with a monoclonal antibody in collagen bands of nodular sclerosis Hodgkin's disease.

A. Epstein, M. Samoszuk, S. Sholly, 1987, Laboratory investigation; a journal of technical methods and pathology.

Treatment of experimental pancreatic cancer with 213-Bismuth-labeled chimeric antibody to single-strand DNA

E. Dadachova, A. Epstein, F. Bruchertseifer, 2014, Expert review of anticancer therapy.

Comparative Analysis of Cytokines of Tumor Cell Lines, Malignant and Benign Effusions Around Breast Implants.

David A. Sieber, W. Adams, A. Epstein, 2020, Aesthetic surgery journal.

Monoclonal Lym-1 antibody-dependent cytolysis by neutrophils exposed to granulocyte-macrophage colony-stimulating factor: intervention of FcgammaRII (CD32), CD11b-CD18 integrins, and CD66b glycoproteins.

A. Epstein, F. Dallegri, L. Ottonello, 1999, Blood.

Tumor biology and monoclonal antibodies : overview of basic principles and clinical considerations

L. Khawli, A. Epstein, 1991 .

USC-HN2, a new model cell line for recurrent oral cavity squamous cell carcinoma with immunosuppressive characteristics.

R. Puri, Jing Han, U. Sinha, 2011, Oral oncology.

Immunohistochemical analysis of non-Hodgkin's lymphomas with the monoclonal antibody to follicular center lymphocytes reactive in paraffin sections.

A. Epstein, M. Thamprasert, L. Bhoopat, 1989, Journal of the Medical Association of Thailand = Chotmaihet thangphaet.

Generation of a monoclonal antibody to detect Elastin-Like Polypeptides.

A. Epstein, Zhiyuan Yao, P. Hu, 2019, Biomacromolecules.

Generation of tumor-targeted antibody-CpG conjugates.

L. Khawli, A. Epstein, M. Lechner, 2013, JIM - Journal of Immunological Methods.

T-Cell Depletion + Combination LEC / chTNT-3 Immunotherapy and CD 25 Complete Regression of Experimental Solid Tumors by Updated Version

L. Khawli, A. Epstein, Jiali Li, 2003 .

Localization of monoclonal antibody TNT‐1 in experimental kidney infarction of the mouse

A. Epstein, C. Taylor, I. Renner, 1990, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

T-Cell Depletion + Combination LEC / chTNT-3 Immunotherapy and CD 25 Complete Regression of Experimental Solid Tumors by Updated Version

L. Khawli, A. Epstein, Jiali Li, 2003 .

Flow cytometric quantitation of the proliferation‐associated nuclear antigen p105 and DNA content in advanced gastric cancers

A. Epstein, Y. Yonemura, H. Kimura, 1991, Cancer.